Biomedical Sciences - Pharmacology - M.S. and Ph.D. Download to print

The Master of Science and Ph.D. in Biomedical Sciences–Pharmacology provides substantial opportunity to develop skills based in chemistry and applicable toward developing new approaches to treat disease. The multidisciplinary program is a balance of classroom and laboratory work and involves faculty in chemistry at Kent State University and faculty in anatomy, neurobiology, physiology and pharmacology at NEOUCOMP.
 

M.S.: Official transcript(s), 3.0 GPA, GRE, goal statement and three letters of recommendation. The M.S. also requires a bachelor's degree with preparation adequate to perform graduate work in the desired field. This commonly includes two years of chemistry, one year of mathematics, one year of physics and courses in anthropology, biology and psychology as appropriate to the field. Admission with deficiencies may be accorded, but these must be made up during the first two years of graduate study.

Ph.D.: Admission to the Ph.D. also requires either completion of the M.S. or direct matriculation to the doctoral program following completion of no less than 20 hours of graduate coursework (including the core) and will be accorded upon the recommendation of the student’s guidance committee and the school director.
 

As soon after completion of the candidacy examination as possible, the dissertation committee will be established consisting of the guidance committee and an outside discipline member — a graduate faculty member from another department at Kent State University or another program committee of the School of Biomedical Sciences. The student will submit to this committee his/her prospectus for the dissertation. The format of the prospectus will parallel that utilized for NIH grant proposals (without biographical, budget and facilities information). The dissertation committee may elect to examine the candidate on the proposal, may accept it as submitted, or may reject it with specific reasons and recommendations for reformulation.